Earnings call: PolyPid s Q3 2023 financial results show decreased expenses and progress in SHIELD II trial By Investing com investing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investing.com Daily Mail and Mail on Sunday newspapers.
Baxter BioPharma Solutions to perform fill/finish services for Moderna’s COVID-19 vaccine Baxter BioPharma Solutions will provide fill/finish sterile manufacturing services and supply packaging for approximately 60-90 million doses of Moderna’s COVID-19 vaccine this year.
The agreement will help Moderna scale up manufacturing capacity in the US as it seeks to reach its target of 1 billion doses globally in 2021.
Manufacture will take place at BioPharma Solutions’ fill/finish sterile manufacturing facilities located in Bloomington, Indiana. The site has capabilities and expertise in parenteral delivery systems and clinical and commercial vaccine manufacturing, including preventive and seasonal vaccines for global markets.
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America ( Brazil, Argentina, Colombia and Chile etc.)
Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)
Key features of this report are:
1.It provides valuable insights into the Global Prefilled Syringe Market.
2.Provides information for the years 2021-2027. Important factors related to the market are mentioned.
3.Technological advancements, government regulations, and recent developments are highlighted.
4.Advertising and marketing strategies, market trends, and analysis are studied in this report.
5.Growth analysis and predictions until the year 2027.
6.Statistical analysis of the key players in the market is highlighted.